The system recorded total operating revenues of $2.7 billion for the three months ended Sept. 30, up from $2.5 billion posted during the same quarter last year. Net patient service revenues were $2.6 billion, up from $2.3 billion over the same period last year.
NewYork-Presbyterian recorded total operating expenses of $2.6 billion in the third quarter of 2024, up from $2.4 billion during the same period last year. Salary and wage costs were $1.3 billion in the quarter, up from $1.1 billion. Supplies and other expenses totaled $896.9 million, up from $861.5 million over the same period last year.
The system had 366.9 days cash on hand as of Sept. 30, up from 345.2 on Dec. 31. NewYork-Presbyterian had a long-term debt of $3.9 billion on Sept. 30.
Net income for the third quarter was $493.9 million, up from $96.1 million during the same quarter last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
